Business & Economy
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
Business & Economy 
Story intelligence
Coverage Single outlet Single-outlet story
Views New Be the first to read
Brief read Under 1 min brief 18 words
Summary
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Business & Economy
Continue reading recent Business & Economy coverage
- Inside Man: How Chinese spies used lies, love and betrayal to target the Federal ReserveContinue reading
- DeepSeek and Huawei Target a Key Source of Nvidia’s A.I. DominanceContinue reading
- Tuesday was one of the most disturbing days for markets in recent memory, according to a Goldman Sachs proContinue reading
- Trump and Tehran are boxed in until the midterms because Iran wants to keep U.S. gas prices high and the president can’t accept ‘surrender’Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow